pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,180 catalysts · 5,539 phase readout · 2,295 8k filing · 343 pdufa · 240 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 47 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,539
  • 8k filing2,295
  • pdufa343
  • earnings240
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07462039: Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing

Sponsor: Eastern Mediterranean University. Phase: NA. Conditions: Nurse's Role, Pain Management, Cervical Cancer Screening, Anxiety

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07555639: An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: Colon Cancer, Breast Cancer, Ovarian Cancer, Genetic Risk Factors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06737432: Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.

Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Ventilation, ARDS, Respiratory Failure, Mechanical Ventilation, Ventilator-induced Lung Injury (VILI), Quality Improvement, Ventilator Associated Events

full page →ctgov ↗
›COMPLETEDphase readoutNCT05499832: Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE3. Conditions: Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07205198: A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Sponsor: Shanghai Institute Of Biological Products. Phase: PHASE1. Conditions: Advanced Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT06321198: A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Sponsor: Anhui Provincial Hospital. Phase: NA. Conditions: Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06264063: Study of Behavioral Dysfunctions and Related Neuronal Correlates in Patients With Dystonia

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: NA. Conditions: Dystonia, Neurologic Disorder, NEUROSCIENCE

full page →ctgov ↗
›COMPLETEDphase readoutNCT02799004: How Much Opioids Do You Need After Your Emergency Department Visit

Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal. Phase: . Conditions: Acute Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07141004: A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Sponsor: Johnson & Johnson Private Limited. Phase: PHASE4. Conditions: Arthritis, Psoriatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07132684: Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE3. Conditions: AML, Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT07466433: Apical Preparation Size in Regenerative Endodontics of Mature Teeth

Sponsor: Marmara University. Phase: NA. Conditions: Apical Periodontitis, Mature Teeth, Regenerative Endodontic Treatment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07372352: Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Peripheral T Cells Lymphoma (PTCL)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06974149: Effects of Transcranial Direct Current Stimulation Associated With Neurofunctional Rehabilitation in Individuals With Spinocerebellar Ataxias

Sponsor: Federal University of Health Science of Porto Alegre. Phase: NA. Conditions: Ataxias Espinocerebelares

full page →ctgov ↗
›COMPLETEDphase readoutNCT05751655: Observational Study of Drowning Patient's Emergency Care in Its Pre-hospital Phase.

Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: . Conditions: Drowning

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07602855: A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Solid Tumors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05500326: Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

Sponsor: Murdoch Childrens Research Institute. Phase: PHASE2. Conditions: Scabies; Itch, Scabies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04217278: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06258278: Clinical Results of Arthroscopic-Assisted Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears

Sponsor: Gazi University. Phase: NA. Conditions: Massive Irreparable Rotator Cuff Tears

full page →ctgov ↗
›RECRUITINGphase readoutNCT07607678: A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Solid Cancer, Metastatic Solid Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05972343: COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Sponsor: Washington University School of Medicine. Phase: . Conditions: Breast Cancer, Cancer of the Breast

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02810743: Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer

Sponsor: The Netherlands Cancer Institute. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07561515: Integrative Use of Sound Therapy for Mental Health Promotion

Sponsor: Federal University of Minas Gerais. Phase: NA. Conditions: Sound Therapy, Music Therapy, Mental Health, Anxiety, Stress, Depression, Quality of Life, Acoustic Resonance, Insonia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07400315: First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Gastric or Gastroesophageal Junction Adenocarcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07066215: Effects of Balance and Muscle Strength in Knee Osteoarthritis

Sponsor: Bezmialem Vakif University. Phase: . Conditions: Primary Knee Osteoarthritis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07336615: A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals

Sponsor: ClostraBio Inc.. Phase: NA. Conditions: Gastrointestinal, Overweight , Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477015: Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Autoimmune Encephalitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06890078: Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Pneumocystis, Immunocompromised Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT05348785: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Sponsor: Biogen. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06344143: Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

Sponsor: The Cleveland Clinic. Phase: . Conditions: Mild Autonomous Cortisol Secretion (MACS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07114315: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Sponsor: Akeso. Phase: PHASE2. Conditions: Pancreatic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05688215: Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03059485: DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE2. Conditions: Acute Myelogenous Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06309485: Phase 2 Study of WGI-0301 for Advanced HCC

Sponsor: Zhejiang Haichang Biotech Co., Ltd.. Phase: PHASE2. Conditions: Advanced Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05849285: Evaluation of the Transitional and Lifelong Care Program

Sponsor: Western University, Canada. Phase: . Conditions: Cerebral Palsy, Spina Bifida, Developmental Disability

full page →ctgov ↗
›COMPLETEDphase readoutNCT07501312: Remote Microphone Performance Comparison in Adults With Hearing Loss

Sponsor: Sonova AG. Phase: NA. Conditions: Hearing Loss

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07423312: Lead Exposure and Multiple Sclerosis

Sponsor: Assiut University. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07445828: Evaluation of Capsule Colonoscopy in Patients With Lynch Syndrome

Sponsor: Region Skane. Phase: . Conditions: Lynch Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07352228: Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices

Sponsor: Xijing Hospital. Phase: PHASE4. Conditions: Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol

full page →ctgov ↗
›COMPLETEDphase readoutNCT07429565: Testing APPA-1 in Healthy Subjects and Osteoarthritis Patients

Sponsor: University of Liverpool. Phase: PHASE1. Conditions: Osteoarthritis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06731465: Efficiency, Efficacy, Periodontal & Occlusal Outcomes for Aligners Versus Fixed Orthodontic Appliances in Crowded Incisor Treatment

Sponsor: University of Sharjah. Phase: NA. Conditions: Crowding of Anterior Mandibular Teeth

full page →ctgov ↗
›COMPLETEDphase readoutNCT03194165: Population Pharmacokinetics of Antiretroviral in Children

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed

full page →ctgov ↗
›RECRUITINGphase readoutNCT00756665: Prostate Active Surveillance Study

Sponsor: University of Washington. Phase: . Conditions: Prostatic Neoplasms

full page →ctgov ↗
›COMPLETEDphase readoutNCT07500467: Upadacitinib for Refractory Takayasu Arteritis

Sponsor: Liu Tian. Phase: . Conditions: Takayasu Arteritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04681807: Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

Sponsor: The Royal Ottawa Mental Health Centre. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04993807: Data-driven SDM to Reduce Symptom Burden in AF

Sponsor: Columbia University. Phase: NA. Conditions: Atrial Fibrillation, Patient Engagement

full page →ctgov ↗
›RECRUITINGphase readoutNCT06442592: Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Congenital Heart Defects, Neurodevelopmental Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06332092: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

Sponsor: Fulgent Pharma LLC.. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07455136: A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

Sponsor: Hoffmann-La Roche. Phase: . Conditions: Traumatic Brain Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT06953336: Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Food Insecurity, Kidney Transplant

full page →ctgov ↗
›RECRUITINGphase readoutNCT05361811: Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Sponsor: National Cancer Institute (NCI). Phase: NA. Conditions: Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome

full page →ctgov ↗
← prev
page 96 of 164
next →